ArticleFrontiers in psychiatry2025
Prevalence of alcohol and substance use relapse in forensic inpatients with substance use disorders in Germany.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Offenders who pose a risk of harm and whose convictions are linked to substance use can be mandated to undergo treatment in forensic psychiatric hospitals under Section 64 StGB of the German Penal Code (Strafsgesetzbuch; StGB), if there are reasonable prospects that treatment might be successful. Relapses during treatment is a common occurrence in patients with substance use disorders but little is known about the frequencies of such events in a forensic setting. Purpose: This study aimed to determine the prevalence of relapse among patients who undergo treatment under § 64 StGB, identify substances involved and possible predictive factors. Method: We utilized data over the span of two years from 108 patients who were admitted to the Clinic of Forensic Psychiatry in Rostock, Germany, between 2019 and 2021.We used descriptive statistics and multiple regression analysis. A relapse was defined as a positive laboratory test for illicit drugs or alcohol, admission of relapsing or a declined test (i. e. the patient did not consent to the test). Results: We found that 65.7% of the patients relapsed within the initial two-year period of stay. Cannabinoids were the most commonly consumed substances. Factors such as age, education level, comorbidity, number of previous convictions, duration of stay and type of substance used did not significantly affect relapse rates. Results are limited by a small sample size. Conclusion: A high relapse rate is still a reality of forensic addiction treatment. Static factors alone might only have a small predictive value for substance relapses and are not sufficient to fully predict individual risk. Therefore our findings show a need to focus on dynamic factors that affect consumption relapse rates. Considering the findings of this research, future studies should investigate dynamic factors of the patient's substance use behavior during treatment as a whole (e.g. reason for relapsing, choice of drug etc.), identify and investigate other factors affecting relapse rate and uncover possible treatment interventions that might reduce relapse rates, dropout rates and criminal recidivism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.